What is the Elmiron Lawsuit About?
Patients who were prescribed Elmiron and developed maculopathy and vision problems have accused Janssen Pharmaceuticals, the drug’s manufacturer, of failing to warn the public about the risks of ocular toxicity and potentially permanent vision damage or loss. In 2019, the American Academy of Ophthalmology researchers presented findings that showed links between PPS use and vision-threatening eye conditions and changes in the macula. If you were prescribed Elmiron and developed changes in your vision, you could be eligible for an Elmiron vision loss and blindness lawsuit. Contact an Elmiron vision loss lawyer to learn more.